Literature DB >> 6201072

Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix.

J M Niloff, T L Klug, E Schaetzl, V R Zurawski, R C Knapp, R C Bast.   

Abstract

An immunoradiometric assay with the use of a monoclonal antibody can detect an antigenic determinant (CA125) in peripheral blood from more than 80% of patients with epithelial ovarian cancer. In this report elevated levels of CA125 were detected in serum from patients with adenocarcinomas of the fallopian tube, endometrium, and endocervix. Among patients with endometrial cancer, CA125 levels were elevated in recurrent or disseminated disease but not with tumors confined to the uterus.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6201072     DOI： 10.1016/s0002-9378(84)90444-7

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


  37 in total

1.  Serum HE4 is correlated to prognostic factors and survival in patients with endometrial cancer.

Authors:  A Stiekema; Car Lok; C M Korse; W J van Driel; V van der Noort; G G Kenter; K K Van de Vijver
Journal:  Virchows Arch       Date:  2017-04-11       Impact factor: 4.064

2.  Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma.

Authors:  Gloria S Huang; Lydia G Chiu; Juliana S Gebb; Marc J Gunter; Paniti Sukumvanich; Gary L Goldberg; Mark H Einstein
Journal:  Gynecol Oncol       Date:  2007-10-23       Impact factor: 5.482

3.  Amino acid profile index for early detection of endometrial cancer: verification as a novel diagnostic marker.

Authors:  Yutaka Ihata; Etsuko Miyagi; Reiko Numazaki; Takahiko Muramatsu; Akira Imaizumi; Hiroshi Yamamoto; Minoru Yamakado; Naoyuki Okamoto; Fumiki Hirahara
Journal:  Int J Clin Oncol       Date:  2013-05-23       Impact factor: 3.402

4.  Serum and tissue measurements of CA72-4 in patients with endometrial carcinoma.

Authors:  H Hareyama; N Sakuragi; S Makinoda; S Fujimoto
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

5.  Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.

Authors:  J B Welsh; P P Zarrinkar; L M Sapinoso; S G Kern; C A Behling; B J Monk; D J Lockhart; R A Burger; G M Hampton
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

6.  The clinical relevance of rising CA-125 levels within the normal range in patients with uterine papillary serous cancer.

Authors:  Marina Frimer; June Y Hou; Thomas C McAndrew; Gary L Goldberg; Shohreh Shahabi
Journal:  Reprod Sci       Date:  2012-09-20       Impact factor: 3.060

Review 7.  Circulating Micro-RNAs as Diagnostic Biomarkers for Endometriosis: Privation and Promise.

Authors:  Warren B Nothnick; Ayman Al-Hendy; John R Lue
Journal:  J Minim Invasive Gynecol       Date:  2015-03-07       Impact factor: 4.137

8.  Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes.

Authors:  Jennifer A Belisle; Sachi Horibata; Gubbels A A Jennifer; Sarah Petrie; Arvinder Kapur; Sabine André; Hans-Joachim Gabius; Claudine Rancourt; Joseph Connor; James C Paulson; Manish S Patankar
Journal:  Mol Cancer       Date:  2010-05-24       Impact factor: 27.401

9.  The detection, treatment, and biology of epithelial ovarian cancer.

Authors:  Jennifer Aa Gubbels; Nick Claussen; Arvinder K Kapur; Joseph P Connor; Manish S Patankar
Journal:  J Ovarian Res       Date:  2010-03-29       Impact factor: 4.234

10.  Preoperative and postoperative CA-125 serum levels in primary fallopian tube carcinoma.

Authors:  A C Rosen; M Klein; H R Rosen; A H Graf; M Lahousen; A Reiner; N Vavra; L Auerbach
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.